Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis

By Balkrishnan Rajesh   Rajagopalan Rukmini   Shenolikar Rahul A.   Camacho Fabian T.   Whitmire J. Timothy   Anderson Roger T.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1633-1640

Informa Healthcare

Access to resources Recommend Favorite

Multi‐country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED)

By  

DIABETIC MEDICINE, Vol. 32, Iss. 6, 2015-06 ,pp. : 819-828

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcomes and resource use after 24 months of insulin therapy in Turkish patients with type 2 diabetes: subgroup analysis of the TREAT study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 5, 2015-05 ,pp. : 588-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1221-1235

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

By Xie Lin   Wei Wenhui   Pan Chunshen   Baser Onur  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite